QIAGEN N.V. QGEN recently secured FDA clearance for the QIAstat-Dx Respiratory Panel Plus syndromic test. Previously authorized under the FDA Emergency Use Authorization (“EUA”) as the QIAstat-Dx ...
Today, OGT announced the launch of a new next-generation sequencing (NGS) panel for Measurable Residual Disease (MRD) - the SureSeq™ Myeloid MRD Plus NGS Panel. Designed using OGT’s 30 years of ...
Barb, the audience measurement and television ratings organisation, has announced the commissioning of two prototypes and two new data sources for Barb Panel Plus, which extends Barb’s use of big data ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results